The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2025, along with the Limited Review Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Ltd reported strong top-line growth for the quarter and nine months ended December 31, 2025. Standalone revenue from operations jumped to ₹4,450.93 lakhs in Q3 FY26 from ₹2,563.21 lakhs in Q3 FY25, a rise of about 74%, while 9M FY26 revenue surged to ₹10,705.27 lakhs from ₹5,099.27 lakhs, more than doubling year-on-year. Profit before tax for 9M FY26 grew roughly 50% to ₹340.20 lakhs (standalone) and ₹341.58 lakhs (consolidated), though Q3 PBT was almost flat at around ₹103-105 lakhs. Standalone EPS for 9M FY26 stood at ₹0.70 versus ₹0.47 last year. The auditor (AJMS & Co LLP) gave an unqualified limited review conclusion but flagged that revenue from operations includes income from trading in shares and securities. The company also noted a shift of its registered office from New Delhi to Goregaon, Mumbai in December 2025 and a grant of 5,892 ESOPs approved in January 2026.
The sharp revenue growth is a positive signal, but the auditor's emphasis that a chunk of it comes from trading in shares and securities suggests core business quality needs to be watched. Mixed near-term picture: flat Q3 profit but strong cumulative profit growth, with margins appearing thin given the stock-in-trade-heavy cost structure.